Next Generation Biopharmaceutical Product Candidates for Hemostasis
Abstract
Technology development, pre-clinical and early-clinical demonstration, and transition of new blood products with increased shelf life and functionality. Cold-stored platelets and fibrinogen replacement technologies will improve prompt hemorrhage control and minimize sustainment requirements.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2020
- Source ID
- 6ef37eaf4e13605c305ab9fdfe9c4af3